UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Leukemia, 2014-07, Vol.28 (7), p.1472-1477

2014

Volltextzugriff (PDF)

Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function

Neuroscience, 2015-11, Vol.309, p.68-83

2015

Volltextzugriff (PDF)

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Leukemia, 2014-07, Vol.28 (7), p.1494-1500

2014

Volltextzugriff (PDF)

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

Leukemia, 2009-05, Vol.23 (5), p.900-904

2009

Volltextzugriff (PDF)

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms

Leukemia, 2010-06, Vol.24 (6), p.1146-1151

2010

Volltextzugriff (PDF)

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Leukemia, 2009-05, Vol.23 (5), p.905-911

2009

Volltextzugriff (PDF)

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

Leukemia, 2014-11, Vol.28 (11), p.2206-2212

2014

Volltextzugriff (PDF)

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Leukemia, 2014-09, Vol.28 (9), p.1804-1810

2014

Volltextzugriff (PDF)

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

Leukemia, 2014-07, Vol.28 (7), p.1568-1570

2014

Volltextzugriff (PDF)

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Leukemia, 2013-06, Vol.27 (6), p.1322-1327

2013

Volltextzugriff (PDF)

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

Leukemia, 2012-03, Vol.26 (3), p.475-480

2012

Volltextzugriff (PDF)

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

Leukemia, 2012-05, Vol.26 (5), p.1135-1137

2012

Volltextzugriff (PDF)

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Leukemia, 2010-07, Vol.24 (7), p.1302-1309

2010

Volltextzugriff (PDF)

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Blood cancer journal (New York), 2017-12, Vol.7 (12), p.662-662, Article 662

2017

Volltextzugriff (PDF)

Neuronal autoantibodies associated with cognitive impairment in melanoma patients

Annals of oncology, 2019-05, Vol.30 (5), p.823-829

2019

Volltextzugriff (PDF)

MRI Findings Suggestive of Herpes Simplex Encephalitis in Patients with Anti-NMDA Receptor Encephalitis

American journal of neuroradiology : AJNR, 2018-11, Vol.39 (11), p.E120-E120

2018

Volltextzugriff (PDF)

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients

Leukemia, 2012-01, Vol.26 (1), p.101-105

2012

Volltextzugriff (PDF)

Mutations and prognosis in primary myelofibrosis

Leukemia, 2013-09, Vol.27 (9), p.1861-1869

2013

Volltextzugriff (PDF)

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

Leukemia, 2018-03, Vol.32 (3), p.837-839

2018

Volltextzugriff (PDF)

Calreticulin mutations and long-term survival in essential thrombocythemia

Leukemia, 2014-12, Vol.28 (12), p.2300-2303

2014

Volltextzugriff (PDF)

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Leukemia, 2013-07, Vol.27 (7), p.1504-1510

2013

Volltextzugriff (PDF)

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera

Leukemia, 2007-09, Vol.21 (9), p.1960-1963

2007

Volltextzugriff (PDF)

Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue

Multiple sclerosis, 2015-06, Vol.21 (7), p.925-934

2015

Volltextzugriff (PDF)

Cognitive impact of neuronal antibodies: encephalitis and beyond

Translational psychiatry, 2020-09, Vol.10 (1), p.304-304, Article 304

2020

Volltextzugriff (PDF)

Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

Leukemia, 2008-04, Vol.22 (4), p.756-761

2008

Volltextzugriff (PDF)

1 – 25 von 1.383

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.099)
Mit Volltextzugriff
(1.162)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.158)
Französisch
(116)
Deutsch
(115)
Japanisch
(5)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Neuronal autoantibodies associated with cognitive impairment in melanoma patients

MRI Findings Suggestive of Herpes Simplex Encephalitis in Patients with Anti-NMDA Receptor Encephalitis

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic Study of 277 patients

Mutations and prognosis in primary myelofibrosis

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

Calreticulin mutations and long-term survival in essential thrombocythemia

Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes

Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera

Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue

Cognitive impact of neuronal antibodies: encephalitis and beyond

Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

Suchergebnisse filtern